[go: up one dir, main page]
Receptor, Platelet-Derived Growth Factor beta

"Receptor, Platelet-Derived Growth Factor beta" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
Definition   |   Details   |   More General Concepts   |   Related Concepts   |   More Specific Concepts
A PDGF receptor that binds specifically to the PDGF-B chain. It contains a protein-tyrosine kinase activity that is involved in SIGNAL TRANSDUCTION.


expand / collapse Publications
This graph shows the total number of publications written about "Receptor, Platelet-Derived Growth Factor beta" by people in this website by year, and whether "Receptor, Platelet-Derived Growth Factor beta" was a major or minor topic of these publications.
Below are the most recent publications written about "Receptor, Platelet-Derived Growth Factor beta" by people in Profiles.
  1. Decreased functional connectivity is associated with increased levels of Cerebral Spinal Fluid soluble-PDGFRβ, a marker of blood brain barrier breakdown, in older adults. Brain Imaging Behav. 2024 Dec; 18(6):1343-1354.
    View in: PubMed
  2. Vascular architecture regulates mesenchymal stromal cell heterogeneity via P53-PDGF signaling in the mouse incisor. Cell Stem Cell. 2024 Jun 06; 31(6):904-920.e6.
    View in: PubMed
  3. Lineage tracing reveals a novel PDGFRβ+ satellite cell subset that contributes to myo-regeneration of chronically injured rotator cuff muscle. Sci Rep. 2024 04 26; 14(1):9668.
    View in: PubMed
  4. Heterogeneous pdgfrb+ cells regulate coronary vessel development and revascularization during heart regeneration. Development. 2022 02 15; 149(4).
    View in: PubMed
  5. Somatic Mosaicism of a PDGFRB Activating Variant in Aneurysms of the Intracranial, Coronary, Aortic, and Radial Artery Vascular Beds. J Am Heart Assoc. 2022 02 15; 11(4):e024289.
    View in: PubMed
  6. The EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and detectable in clinical samples prior to treatment. Haematologica. 2021 08 01; 106(8):2242-2245.
    View in: PubMed
  7. Sulfatase 2 (SULF2) Monoclonal Antibody 5D5 Suppresses Human Cholangiocarcinoma Xenograft Growth Through Regulation of a SULF2-Platelet-Derived Growth Factor Receptor Beta-Yes-Associated Protein Signaling Axis. Hepatology. 2021 09; 74(3):1411-1428.
    View in: PubMed
  8. Segmental overgrowth and aneurysms due to mosaic PDGFRB p.(Tyr562Cys). Am J Med Genet A. 2021 05; 185(5):1430-1436.
    View in: PubMed
  9. Cutaneous acral myofibroma with PDGFRB mutation in a patient with linear morphea en coup de sabre. J Cutan Pathol. 2021 Aug; 48(8):1097-1100.
    View in: PubMed
  10. PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors. Breast Cancer Res. 2021 01 21; 23(1):10.
    View in: PubMed
People
People who have written about this concept.
Explore @UCSD
_
Similar Concepts expand description
Similar concepts derived from published works.
_
Top Journals
Top journals in which articles about this concept have been published.

UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
This site is running Profiles RNS version UCSF-v3.1.0-9-g3adcefa5 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

Copyright © The Regents of the University of California